The Centers for Medicare and Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

CMS's third drug negotiation cycle under the IRA targets high-expenditure drugs, impacting Medicare Part B and D spending. The list includes drugs for cancer, HIV, and diabetes, with significant ...

The federal government is adding costly blockbuster drugs that help patients lose weight to the list of medications for which Medicare plans on negotiating lower prices in the coming years. The move ...